ProShare Advisors »

Rapport Therapeutics shares owned by ProShare Advisors

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by ProShare Advisors from 13F filings

Historical chart of ProShare Advisors investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by ProShare Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by ProShare Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $222k 7.3k 30.34

More positions owned by ProShare Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)
Micron Technology (MU)
Cisco Systems (CSCO)

View all positions for ProShare Advisors

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics